Study with Diamyd Medical's diabetes vaccine awarded EU-funding

Diamyd Medical informs that the ongoing combination study DIABGAD has been awarded EUR 120 000, corresponding to about SEK 1.1 million, in EU-funding.

http://ift.tt/1qtTgZ1